SLC25A36 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.992100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.118400E-01
Normal-vs-Stage2
7.484000E-02
Normal-vs-Stage3
5.960100E-02
Normal-vs-Stage4
3.668800E-01
Stage1-vs-Stage2
5.793400E-01
Stage1-vs-Stage3
9.704200E-02
Stage1-vs-Stage4
9.381000E-01
Stage2-vs-Stage3
1.497010E-01
Stage2-vs-Stage4
7.192200E-01
Stage3-vs-Stage4
1.493440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.727700E-02
Normal-vs-AfricanAmerican
3.031600E-01
Normal-vs-Asian
1.556160E-01
Caucasian-vs-AfricanAmerican
8.582000E-01
Caucasian-vs-Asian
5.945000E-01
AfricanAmerican-vs-Asian
7.025400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.176000E-02
Normal-vs-Female
1.156200E-01
Male-vs-Female
3.464000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.202400E-01
Normal-vs-Age(41-60Yrs)
2.303800E-01
Normal-vs-Age(61-80Yrs)
3.832300E-02
Normal-vs-Age(81-100Yrs)
7.243700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.801200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.241600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.063400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.321200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.942100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.063600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.579500E-02
Normal-vs-Daily Drinker
4.473800E-02
Normal-vs-Weekly Drinker
1.606390E-02
Normal-vs-Occasional Drinker
2.666800E-01
Normal-vs-Social Drinker
4.624400E-01
Non Drinker-vs-Daily Drinker
8.526200E-01
Non Drinker-vs-Weekly Drinker
4.621200E-01
Non Drinker-vs-Occasional Drinker
2.169200E-01
Non Drinker-vs-Social Drinker
1.057600E-01
Daily Drinker-vs-Weekly Drinker
5.677200E-01
Daily Drinker-vs-Occasional Drinker
1.828030E-01
Daily Drinker-vs-Social Drinker
9.578100E-02
Weekly Drinker-vs-Occasional Drinker
8.963600E-02
Weekly Drinker-vs-Social Drinker
5.437800E-02
Occasional Drinker-vs-Social Drinker
6.571800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.372200E-02
Normal-vs-Grade 2
4.875100E-03
Normal-vs-Grade 3
2.105600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.801040E-01
Grade 1-vs-Grade 3
1.241640E-01
Grade 1-vs-Grade 4
7.372200E-02
Grade 2-vs-Grade 3
4.431000E-01
Grade 2-vs-Grade 4
4.875100E-03
Grade 3-vs-Grade 4
2.105600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.555800E-03
Normal-vs-NonDiabetic
1.040380E-01
Diabetic-vs-NonDiabetic
3.303800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.125780E-01
Normal-vs-NoPancreatitis
5.730200E-02
Pancreatitis-vs-NoPancreatitis
8.783000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.916000E-02
Normal-vs-N1
6.753800E-02
N0-vs-N1
5.853600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.931840E-01
Normal-vs-TP53-NonMutant
1.688050E-01
TP53-Mutant-vs-TP53-NonMutant
4.850200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
